{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:34:03Z","timestamp":1787243643721,"version":"build-2736575974"},"reference-count":108,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.modpat.2024.100631","type":"journal-article","created":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T18:00:11Z","timestamp":1728756011000},"page":"100631","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Digital and Computational Pathology Applications in Bladder Cancer: Novel Tools Addressing Clinically Pressing Needs"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6829-1391","authenticated-orcid":false,"given":"Jo\u00e3o","family":"Lobo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bassel","family":"Zein-Sabatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priti","family":"Lal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George J.","family":"Netto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/j.modpat.2024.100631_bib1","article-title":"Effectiveness and cost-effectiveness of artificial intelligence-assisted pathology for prostate cancer diagnosis in Sweden: a microsimulation study","volume":"S2588-9311","author":"Du","year":"2024","journal-title":"Eur Urol Oncol"},{"issue":"1","key":"10.1016\/j.modpat.2024.100631_bib2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4103\/2153-3539.139714","article-title":"Can digital pathology result in cost savings? A financial projection for digital pathology implementation at a large integrated health care organization","volume":"5","author":"Ho","year":"2014","journal-title":"J\u00a0Pathol Inform"},{"key":"10.1016\/j.modpat.2024.100631_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104427","article-title":"Computational pathology in 2030: a Delphi study forecasting the role of AI in pathology within the next decade","volume":"88","author":"Berb\u00eds","year":"2023","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.modpat.2024.100631_bib4","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.1038\/s41467-020-18918-3","article-title":"Deep transfer learning for reducing health care disparities arising from biomedical data inequality","volume":"11","author":"Gao","year":"2020","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.modpat.2024.100631_bib5","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/s41591-024-02885-z","article-title":"Demographic bias in misdiagnosis by computational pathology models","volume":"30","author":"Vaidya","year":"2024","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.modpat.2024.100631_bib6","doi-asserted-by":"crossref","first-page":"359","DOI":"10.5858\/arpa.2020-0034-OA","article-title":"A\u00a0digital pathology solution to resolve the tissue floater conundrum","volume":"145","author":"Pantanowitz","year":"2021","journal-title":"Arch Pathol Lab Med"},{"issue":"5","key":"10.1016\/j.modpat.2024.100631_bib7","doi-asserted-by":"crossref","first-page":"e253","DOI":"10.1016\/S1470-2045(19)30154-8","article-title":"Digital pathology and artificial intelligence","volume":"20","author":"Niazi","year":"2019","journal-title":"Lancet Oncol"},{"issue":"11","key":"10.1016\/j.modpat.2024.100631_bib8","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/s41571-019-0252-y","article-title":"Artificial intelligence in digital pathology\u2014new tools for diagnosis and precision oncology","volume":"16","author":"Bera","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"10.1016\/j.modpat.2024.100631_bib9","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.eururo.2016.06.010","article-title":"Bladder cancer incidence and mortality: a global overview and recent trends","volume":"71","author":"Antoni","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.modpat.2024.100631_bib10","author":"Ferlay"},{"issue":"3","key":"10.1016\/j.modpat.2024.100631_bib11","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.eururo.2015.10.024","article-title":"Economic burden of bladder cancer across the European Union","volume":"69","author":"Leal","year":"2016","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.modpat.2024.100631_bib12","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00345-009-0395-z","article-title":"Economic aspects of bladder cancer: what are the benefits and costs?","volume":"27","author":"Sievert","year":"2009","journal-title":"World J Urol"},{"issue":"18","key":"10.1016\/j.modpat.2024.100631_bib13","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/BF03262330","article-title":"The health economics of bladder cancer: a comprehensive review of the published literature","volume":"21","author":"Botteman","year":"2003","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"10.1016\/j.modpat.2024.100631_bib14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/path.4886","article-title":"Molecular classification of urothelial carcinoma: global mRNA classification versus tumour-cell phenotype classification","volume":"242","author":"Sj\u00f6dahl","year":"2017","journal-title":"J\u00a0Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2024.100631_bib15","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ccr.2014.01.009","article-title":"Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy","volume":"25","author":"Choi","year":"2014","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.modpat.2024.100631_bib16","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.cell.2018.07.036","article-title":"Comprehensive molecular characterization of muscle-invasive bladder cancer","volume":"174","author":"Robertson","year":"2018","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.modpat.2024.100631_bib17","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.path.2021.05.005","article-title":"Molecular pathology of urothelial carcinoma","volume":"14","author":"Al-Ahmadie","year":"2021","journal-title":"Surg Pathol Clin"},{"issue":"5","key":"10.1016\/j.modpat.2024.100631_bib18","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.eururo.2015.08.034","volume":"69","author":"McConkey","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.modpat.2024.100631_bib19","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ebiom.2016.08.036","article-title":"Meta-analysis of the luminal and basal subtypes of bladder cancer and the identification of signature immunohistochemical markers for clinical use","volume":"12","author":"Dadhania","year":"2016","journal-title":"EBioMedicine"},{"issue":"3","key":"10.1016\/j.modpat.2024.100631_bib20","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00428-019-02618-5","article-title":"Immunohistochemical assessment of basal and luminal markers in non-muscle invasive urothelial carcinoma of bladder","volume":"475","author":"Rodriguez Pena","year":"2019","journal-title":"Virchows Arch"},{"key":"10.1016\/j.modpat.2024.100631_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2019.08.001","article-title":"Prognostic stratification of muscle invasive urothelial carcinomas using limited immunohistochemical panel of Gata3 and cytokeratins 5\/6, 14 and 20","volume":"43","author":"Jangir","year":"2019","journal-title":"Ann Diagn Pathol"},{"issue":"14","key":"10.1016\/j.modpat.2024.100631_bib22","doi-asserted-by":"crossref","first-page":"7844","DOI":"10.3390\/ijms23147844","article-title":"Are we ready to implement molecular subtyping of bladder cancer in clinical practice? part 2: subtypes and divergent differentiation","volume":"23","author":"Sanguedolce","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.modpat.2024.100631_bib23","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s12967-020-02475-w","article-title":"Practicability of clinical application of bladder cancer molecular classification and additional value of epithelial-to-mesenchymal transition: prognostic value of vimentin expression","volume":"18","author":"Lobo","year":"2020","journal-title":"J\u00a0Transl Med"},{"issue":"2","key":"10.1016\/j.modpat.2024.100631_bib24","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.eururo.2020.04.023","article-title":"Deep learning predicts molecular subtype of muscle-invasive bladder cancer from conventional histopathological slides","volume":"78","author":"Woerl","year":"2020","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.modpat.2024.100631_bib25","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.euf.2021.04.007","article-title":"Artificial intelligence-based detection of FGFR3 mutational status directly from routine histology in bladder cancer: a possible preselection for molecular testing?","volume":"8","author":"Loeffler","year":"2022","journal-title":"Eur Urol Focus"},{"issue":"1","key":"10.1016\/j.modpat.2024.100631_bib26","article-title":"Artificial intelligence meets whole slide images: deep learning model shapes an immune-hot tumor and guides precision therapy in bladder cancer","volume":"2022","author":"Jiang","year":"2022","journal-title":"J\u00a0Oncol"},{"issue":"5","key":"10.1016\/j.modpat.2024.100631_bib27","first-page":"152","article-title":"A\u00a0review of current advancements and limitations of artificial intelligence in genitourinary cancers","volume":"8","author":"Pai","year":"2020","journal-title":"Am J Clin Exp Urol"},{"issue":"4","key":"10.1016\/j.modpat.2024.100631_bib28","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/MOU.0000000000000900","article-title":"European Association of Urology \u2013 Young Academic Urologists (EAU-YAU) Urothelial Carcinoma Working Group. The use of artificial intelligence for the diagnosis of bladder cancer: a review and perspectives","volume":"31","author":"Chan","year":"2021","journal-title":"Curr Opin Urol"},{"issue":"2","key":"10.1016\/j.modpat.2024.100631_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210976","article-title":"Machine learning models for predicting post-cystectomy recurrence and survival in bladder cancer patients","volume":"14","author":"Hasnain","year":"2019","journal-title":"PloS one"},{"issue":"2","key":"10.1016\/j.modpat.2024.100631_bib30","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1177\/0391560320987169","article-title":"Bladder cancer in the time of machine learning: intelligent tools for diagnosis and management","volume":"88","author":"Gandi","year":"2021","journal-title":"Urologia"},{"issue":"1","key":"10.1016\/j.modpat.2024.100631_bib31","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3390\/biomedinformatics3010008","article-title":"Artificial intelligence in bladder cancer diagnosis: current applications and future perspectives","volume":"3","author":"Rossin","year":"2023","journal-title":"BioMedInformatics"},{"issue":"20","key":"10.1016\/j.modpat.2024.100631_bib32","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.3390\/cancers14205019","article-title":"Predicting recurrence of non-muscle-invasive bladder cancer: current techniques and future trends","volume":"14","author":"Shalata","year":"2022","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.modpat.2024.100631_bib33","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/MOU.0000000000000882","article-title":"Artificial intelligence in bladder cancer prognosis: a pathway for personalized medicine","volume":"31","author":"Pinar","year":"2021","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.modpat.2024.100631_bib34","first-page":"607","article-title":"A\u00a0machine learning approach for long-term prognosis of bladder cancer based on clinical and molecular features","volume":"2020","author":"Song","year":"2020","journal-title":"AMIA Summits Transl Sci Proc"},{"key":"10.1016\/j.modpat.2024.100631_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2020.05.009","article-title":"Development of robust artificial neural networks for prediction of 5-year survival in bladder cancer","volume":"39","author":"Bhambhvani","year":"2021","journal-title":"Urol Oncol"},{"issue":"1","key":"10.1016\/j.modpat.2024.100631_bib36","doi-asserted-by":"crossref","first-page":"8738","DOI":"10.1038\/s41598-017-09315-w","article-title":"Bladder cancer treatment response assessment in CT using radiomics with deep-learning","volume":"7","author":"Cha","year":"2017","journal-title":"Sci Rep"},{"issue":"18","key":"10.1016\/j.modpat.2024.100631_bib37","doi-asserted-by":"crossref","first-page":"4518","DOI":"10.3390\/cancers15184518","article-title":"Artificial intelligence in digital pathology for bladder cancer: hype or hope? A systematic review","volume":"15","author":"Khoraminia","year":"2023","journal-title":"Cancers"},{"issue":"23","key":"10.1016\/j.modpat.2024.100631_bib38","doi-asserted-by":"crossref","first-page":"5807","DOI":"10.3390\/cancers14235807","article-title":"Accurate diagnosis and survival prediction of bladder cancer using deep learning on histological slides","volume":"14","author":"Zheng","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.modpat.2024.100631_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/1997\/147187","article-title":"Image analysis based grading of bladder carcinoma. Comparison of object, texture and graph based methods and their reproducibility","volume":"15","author":"Choi","year":"1997","journal-title":"Anal Cell Pathol"},{"issue":"6","key":"10.1016\/j.modpat.2024.100631_bib40","first-page":"331","article-title":"Automated segmentation of routinely hematoxylin-eosin-stained microscopic images by combining support vector machine clustering and active contour models","volume":"26","author":"Glotsos","year":"2004","journal-title":"Anal Quant Cytol Histol"},{"issue":"5-6","key":"10.1016\/j.modpat.2024.100631_bib41","first-page":"283","article-title":"Comparative evaluation of support vector machines and probabilistic neural networks in superficial bladder cancer classification","volume":"6","author":"Spyridonos","year":"2006","journal-title":"J\u00a0Comput Methods Sci Eng"},{"issue":"3","key":"10.1016\/j.modpat.2024.100631_bib42","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.artmed.2006.07.008","article-title":"Cell-nuclear data reduction and prognostic model selection in bladder tumor recurrence","volume":"38","author":"Tasoulis","year":"2006","journal-title":"Artif Intell Med"},{"issue":"4","key":"10.1016\/j.modpat.2024.100631_bib43","first-page":"91","article-title":"Whole slide images for primary diagnostics of urinary system pathology: a feasibility study","volume":"3","author":"Al-Janabi","year":"2014","journal-title":"J\u00a0Renal Inj Prev"},{"issue":"5","key":"10.1016\/j.modpat.2024.100631_bib44","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s42256-019-0052-1","article-title":"Pathologist-level interpretable whole-slide cancer diagnosis with deep learning","volume":"1","author":"Zhang","year":"2019","journal-title":"Nat Mach Intell"},{"issue":"1","key":"10.1016\/j.modpat.2024.100631_bib45","doi-asserted-by":"crossref","first-page":"5174","DOI":"10.1038\/s41598-019-41595-2","article-title":"Automated tumour budding quantification by machine learning augments TNM staging in muscle-invasive bladder cancer prognosis","volume":"9","author":"Brieu","year":"2019","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.modpat.2024.100631_bib46","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13000-019-0803-7","article-title":"Three-dimensional histopathological reconstruction of bladder tumours","volume":"14","author":"Jansen","year":"2019","journal-title":"Diagn Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2024.100631_bib47","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12911-020-01185-z","article-title":"Histopathological distinction of non-invasive and invasive bladder cancers using machine learning approaches","volume":"20","author":"Yin","year":"2020","journal-title":"BMC Med Inform Decis Mak"},{"key":"10.1016\/j.modpat.2024.100631_bib48","doi-asserted-by":"crossref","DOI":"10.1177\/1533033820946787","article-title":"A\u00a0multiscale approach for whole-slide image segmentation of five tissue classes in urothelial carcinoma slides","volume":"19","author":"Wetteland","year":"2020","journal-title":"Technol Cancer Res Treat"},{"issue":"7","key":"10.1016\/j.modpat.2024.100631_bib49","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.ajpath.2020.03.013","article-title":"Automated detection and grading of non\u2013muscle-invasive urothelial cell carcinoma of the bladder","volume":"190","author":"Jansen","year":"2020","journal-title":"Am J Pathol"},{"key":"10.1016\/j.modpat.2024.100631_bib50","article-title":"Bladder cancer prognosis using deep neural networks and histopathology images","volume":"13","author":"Barrios","year":"2022","journal-title":"J\u00a0Pathol Inform"},{"issue":"1","key":"10.1016\/j.modpat.2024.100631_bib51","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13000-020-01002-1","article-title":"Semantic segmentation to identify bladder layers from H&E images","volume":"15","author":"Niazi","year":"2020","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.modpat.2024.100631_bib52","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1200\/CCI.19.00155","article-title":"Multiresolution application of artificial intelligence in digital pathology for prediction of positive lymph nodes from primary tumors in bladder cancer","volume":"4","author":"Harmon","year":"2020","journal-title":"JCO Clin Cancer Inform"},{"issue":"7","key":"10.1016\/j.modpat.2024.100631_bib53","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1111\/cas.14927","article-title":"Clinical use of machine learning-based pathomics signature for diagnosis and survival prediction of bladder cancer","volume":"112","author":"Chen","year":"2021","journal-title":"Cancer Sci"},{"key":"10.1016\/j.modpat.2024.100631_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2021.104932","article-title":"A\u00a0novel self-learning framework for bladder cancer grading using histopathological images","volume":"138","author":"Garc\u00eda","year":"2021","journal-title":"Comput Biol Med"},{"issue":"4","key":"10.1016\/j.modpat.2024.100631_bib55","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41379-021-00955-y","article-title":"Prediction of non-muscle invasive bladder cancer recurrence using machine learning of quantitative nuclear features","volume":"35","author":"Tokuyama","year":"2022","journal-title":"Mod Pathol"},{"issue":"9","key":"10.1016\/j.modpat.2024.100631_bib56","article-title":"Predictive models of response to neoadjuvant chemotherapy in muscle-invasive bladder cancer using nuclear morphology and tissue architecture","volume":"2","author":"Mi","year":"2021","journal-title":"Cell Rep Med"},{"issue":"1","key":"10.1016\/j.modpat.2024.100631_bib57","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1186\/s12885-021-08698-4","article-title":"Validation of grading of non-invasive urothelial carcinoma by digital pathology for routine diagnosis","volume":"21","author":"Colling","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.modpat.2024.100631_bib58","doi-asserted-by":"crossref","first-page":"115813","DOI":"10.1109\/ACCESS.2021.3104724","article-title":"Automatic diagnostic tool for predicting cancer grade in bladder cancer patients using deep learning","volume":"9","author":"Wetteland","year":"2021","journal-title":"IEEE Access"},{"issue":"1","key":"10.1016\/j.modpat.2024.100631_bib59","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.euf.2020.12.008","article-title":"Deep learning-based recurrence prediction in patients with non-muscle-invasive bladder cancer","volume":"8","author":"Lucas","year":"2022","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.modpat.2024.100631_bib60","article-title":"Differentiation of urothelial carcinoma in histopathology images using deep learning and visualization","volume":"14","author":"Mundhada","year":"2023","journal-title":"J\u00a0Pathol Inform"},{"issue":"1","key":"10.1016\/j.modpat.2024.100631_bib61","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12967-023-03888-z","article-title":"An artificial intelligence model for the pathological diagnosis of invasion depth and histologic grade in bladder cancer","volume":"21","author":"Pan","year":"2023","journal-title":"J\u00a0Transl Med"},{"issue":"7","key":"10.1016\/j.modpat.2024.100631_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.labinv.2023.100155","article-title":"Quantitative nuclear grading: an objective, artificial intelligence-facilitated foundation for grading noninvasive papillary urothelial carcinoma","volume":"103","author":"Slotman","year":"2023","journal-title":"Lab Invest"},{"key":"10.1016\/j.modpat.2024.100631_bib63","article-title":"Spatial heterogeneity and organization of tumor mutation burden with immune infiltrates within tumors based on whole slide images correlated with patient survival in bladder cancer","volume":"13","author":"Xu","year":"2022","journal-title":"J\u00a0Pathol Inform"},{"issue":"14","key":"10.1016\/j.modpat.2024.100631_bib64","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.1002\/cam4.4044","article-title":"Using deep learning to identify bladder cancers with FGFR-activating mutations from histology images","volume":"10","author":"Velmahos","year":"2021","journal-title":"Cancer Med"},{"issue":"4","key":"10.1016\/j.modpat.2024.100631_bib65","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S1470-2045(23)00061-X","article-title":"Artificial intelligence-based model for lymph node metastases detection on whole slide images in bladder cancer: a retrospective, multicentre, diagnostic study","volume":"24","author":"Wu","year":"2023","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.modpat.2024.100631_bib66","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.anndiagpath.2018.09.012","article-title":"Mimickers of urothelial neoplasia","volume":"38","author":"Kryvenko","year":"2019","journal-title":"Ann Diagn Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2024.100631_bib67","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41746-020-0238-2","article-title":"Pan-cancer diagnostic consensus through searching archival histopathology images using artificial intelligence","volume":"3","author":"Kalra","year":"2020","journal-title":"npj Digital Med"},{"key":"10.1016\/j.modpat.2024.100631_bib68","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ebiom.2017.12.026","article-title":"Deep convolutional neural networks enable discrimination of heterogeneous digital pathology images","volume":"27","author":"Khosravi","year":"2018","journal-title":"EBioMedicine"},{"issue":"4","key":"10.1016\/j.modpat.2024.100631_bib69","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1159\/000510474","article-title":"Developing a machine learning algorithm for identifying abnormal urothelial cells: a feasibility study","volume":"65","author":"Zhang","year":"2021","journal-title":"Acta Cytol"},{"issue":"10","key":"10.1016\/j.modpat.2024.100631_bib70","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/cncy.22176","article-title":"Performance of an artificial intelligence algorithm for reporting urine cytopathology","volume":"127","author":"Sanghvi","year":"2019","journal-title":"Cancer Cytopathol"},{"issue":"3","key":"10.1016\/j.modpat.2024.100631_bib71","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/bju.15382","article-title":"Artificial intelligence to improve cytology performances in bladder carcinoma detection: results of the VisioCyt test","volume":"129","author":"Lebret","year":"2022","journal-title":"BJU international"},{"issue":"9","key":"10.1016\/j.modpat.2024.100631_bib72","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1007\/s00345-023-04519-4","article-title":"Artificial intelligence to improve cytology performance in urothelial carcinoma diagnosis: results from validation phase of the French, multicenter, prospective VISIOCYT1 trial","volume":"41","author":"Lebret","year":"2023","journal-title":"World J Urol"},{"key":"10.1016\/j.modpat.2024.100631_bib73","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4103\/cytojournal.cytojournal_12_17","article-title":"Interobserver reproducibility of the Paris system for reporting urinary cytology","volume":"14","author":"Long","year":"2017","journal-title":"Cytojournal"},{"key":"10.1016\/j.modpat.2024.100631_bib74","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4103\/cytojournal.cytojournal_30_19","article-title":"Impact of the Paris system for reporting urine cytopathology on predictive values of the equivocal diagnostic categories and interobserver agreement","volume":"16","author":"Bakkar","year":"2019","journal-title":"Cytojournal"},{"issue":"4","key":"10.1016\/j.modpat.2024.100631_bib75","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jasc.2018.02.005","article-title":"Paris interobserver reproducibility study (PIRST)","volume":"7","author":"Kurtycz","year":"2018","journal-title":"J\u00a0Am Soc Cytopathol"},{"issue":"24","key":"10.1016\/j.modpat.2024.100631_bib76","doi-asserted-by":"crossref","first-page":"38802","DOI":"10.18632\/oncotarget.16393","article-title":"Metabolite marker discovery for the detection of bladder cancer by comparative metabolomics","volume":"8","author":"Shao","year":"2017","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.modpat.2024.100631_bib77","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s11306-019-1555-9","article-title":"Recognition of early and late stages of bladder cancer using metabolites and machine learning","volume":"15","author":"Kouznetsova","year":"2019","journal-title":"Metabolomics"},{"issue":"1","key":"10.1016\/j.modpat.2024.100631_bib78","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.humpath.2015.09.007","article-title":"Significance of a minor high-grade component in a low-grade noninvasive papillary urothelial carcinoma of bladder","volume":"47","author":"Reis","year":"2016","journal-title":"Human Pathol"},{"issue":"5","key":"10.1016\/j.modpat.2024.100631_bib79","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.urolonc.2019.10.002","article-title":"Papillary urothelial neoplasm of low malignant potential (PUN-LMP): still a meaningful histo-pathological grade category for Ta, noninvasive bladder tumors in 2019?","volume":"38","author":"Hentschel","year":"2020","journal-title":"Urol Oncol"},{"issue":"7","key":"10.1016\/j.modpat.2024.100631_bib80","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1002\/(SICI)1097-0142(20000401)88:7<1663::AID-CNCR21>3.0.CO;2-8","article-title":"Cancer heterogeneity and its biologic implications in the grading of urothelial carcinoma","volume":"88","author":"Cheng","year":"2000","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.modpat.2024.100631_bib81","first-page":"1693","article-title":"Mixed high and low grade bladder tumors\u2014are they clinically high or low grade?","volume":"191","author":"Gofrit","year":"2014","journal-title":"J\u00a0Urol"},{"issue":"5","key":"10.1016\/j.modpat.2024.100631_bib82","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.eururo.2017.04.015","volume":"72","author":"Soukup","year":"2017","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.modpat.2024.100631_bib83","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S1470-2045(19)30739-9","article-title":"Automated deep-learning system for Gleason grading of prostate cancer using biopsies: a diagnostic study","volume":"21","author":"Bulten","year":"2020","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.modpat.2024.100631_bib84","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/PAP.0000000000000309","article-title":"The genitourinary pathology society update on classification of variant histologies, T1 substaging, molecular taxonomy, and immunotherapy and PD-L1 testing implications of urothelial cancers","volume":"28","author":"Comp\u00e9rat","year":"2021","journal-title":"Adv Anat Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2024.100631_bib85","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.euf.2016.06.004","article-title":"Feasibility and clinical roles of different substaging systems at first and second transurethral resection in patients with T1 high-grade bladder cancer","volume":"4","author":"Colombo","year":"2018","journal-title":"Eur Urol Focus"},{"issue":"6","key":"10.1016\/j.modpat.2024.100631_bib86","first-page":"2069","article-title":"Prognostic interest in discriminating muscularis mucosa invasion (T1a vs T1b) in nonmuscle invasive bladder carcinoma: French national multicenter study with central pathology review","volume":"189","author":"Roupr\u00eat","year":"2013","journal-title":"J\u00a0Urol"},{"issue":"6","key":"10.1016\/j.modpat.2024.100631_bib87","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1007\/s00345-019-02936-y","article-title":"Prognostic value of T1 substaging on oncological outcomes in patients with non-muscle-invasive bladder urothelial carcinoma: a systematic literature review and meta-analysis","volume":"38","author":"Kardoust Parizi","year":"2020","journal-title":"World J Urol"},{"issue":"1","key":"10.1016\/j.modpat.2024.100631_bib88","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.humpath.2012.04.020","article-title":"Prognostic factors in T1 bladder urothelial carcinoma: the value of recording millimetric depth of invasion, diameter of invasive carcinoma, and muscularis mucosa invasion","volume":"44","author":"Brimo","year":"2013","journal-title":"Human Pathol"},{"issue":"4","key":"10.1016\/j.modpat.2024.100631_bib89","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/PAP.0000000000000308","article-title":"The Genitourinary Pathology Society update on classification and grading of flat and papillary urothelial neoplasia with new reporting recommendations and approach to lesions with mixed and early patterns of neoplasia","volume":"28","author":"Amin","year":"2021","journal-title":"Adv Anat Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2024.100631_bib90","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.euo.2023.07.011","article-title":"Proposal for a novel histological scoring system as a potential grading approach for muscle-invasive urothelial bladder cancer correlating with disease aggressiveness and patient outcomes","volume":"7","author":"Eckstein","year":"2024","journal-title":"Eur Urol Oncol"},{"issue":"7","key":"10.1016\/j.modpat.2024.100631_bib91","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/00000478-200007000-00009","article-title":"Grading the invasive component of urothelial carcinoma of the bladder and its relationship with progression-free survival","volume":"24","author":"Jimenez","year":"2000","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.modpat.2024.100631_bib92","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/modpathol.2017.46","article-title":"Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016","volume":"30","author":"Lugli","year":"2017","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.modpat.2024.100631_bib93","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/j.celrep.2019.04.048","article-title":"Dysregulation of EMT drives the progression to clinically aggressive sarcomatoid bladder cancer","volume":"27","author":"Guo","year":"2019","journal-title":"Cell Rep"},{"issue":"9","key":"10.1016\/j.modpat.2024.100631_bib94","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1111\/cas.12990","article-title":"Tumor budding, a novel prognostic indicator for predicting stage progression in T1 bladder cancers","volume":"107","author":"Fukumoto","year":"2016","journal-title":"Cancer Sci"},{"issue":"7492","key":"10.1016\/j.modpat.2024.100631_bib95","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature12965","article-title":"Comprehensive molecular characterization of urothelial bladder carcinoma","volume":"507","year":"2014","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.modpat.2024.100631_bib96","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.eururo.2019.02.017","article-title":"The Cancer Genome Atlas expression subtypes stratify response to checkpoint inhibition in advanced urothelial cancer and identify a subset of patients with high survival probability","volume":"75","author":"Kim","year":"2019","journal-title":"Eur Urol"},{"issue":"12","key":"10.1016\/j.modpat.2024.100631_bib97","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/s41379-018-0096-5","article-title":"Discordant molecular subtype\u00a0classification in the basal-squamous subtype of bladder tumors and matched lymph-node metastases","volume":"31","author":"Sj\u00f6dahl","year":"2018","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2024.100631_bib98","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.21037\/qims-22-679","article-title":"Multimodal investigation of bladder cancer data based on computed tomography, whole slide imaging, and transcriptomics","volume":"13","author":"Wu","year":"2023","journal-title":"Quant Imaging Med Surg"},{"issue":"4","key":"10.1016\/j.modpat.2024.100631_bib99","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1056\/NEJMoa1817323","article-title":"Erdafitinib in locally advanced or metastatic urothelial carcinoma","volume":"381","author":"Loriot","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.modpat.2024.100631_bib100","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.3390\/curroncol29030117","article-title":"Urothelial bladder carcinomas with high tumor mutation burden have a better prognosis and targetable molecular defects beyond immunotherapies","volume":"29","author":"Voutsadakis","year":"2022","journal-title":"Curr Oncol"},{"issue":"25","key":"10.1016\/j.modpat.2024.100631_bib101","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1056\/NEJMc1713444","article-title":"Tumor mutational burden and response rate to PD-1 inhibition","volume":"377","author":"Yarchoan","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.modpat.2024.100631_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2021.153607","article-title":"Development of a multiplex immuno-oncology biomarker and digital pathology workflow for assessment of urothelial carcinoma","volume":"226","author":"Xie","year":"2021","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.modpat.2024.100631_bib103","article-title":"Challenges in implementing a digital pathology workflow in surgical pathology","volume":"29","author":"Lujan","year":"2022","journal-title":"Hum Pathol Rep"},{"key":"10.1016\/j.modpat.2024.100631_bib104","article-title":"Digital pathology - rising to the challenge","volume":"9","author":"Dawson","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"10.1016\/j.modpat.2024.100631_bib105","doi-asserted-by":"crossref","first-page":"221","DOI":"10.5858\/arpa.2018-0541-OA","article-title":"Complete digital pathology for routine histopathology diagnosis in a multicenter hospital network","volume":"144","author":"Retamero","year":"2020","journal-title":"Arch Pathol Lab Med"},{"issue":"11","key":"10.1016\/j.modpat.2024.100631_bib106","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1038\/s41379-020-0601-5","article-title":"Validation of a digital pathology system including remote review during the COVID-19 pandemic","volume":"33","author":"Hanna","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.modpat.2024.100631_bib107","series-title":"Proceedings of the IEEE Conference on Computer Vision and Pattern Recognition","first-page":"6428","article-title":"MDNet: a semantically and visually interpretable medical image diagnosis network","author":"Zhang","year":"2017"},{"issue":"10","key":"10.1016\/j.modpat.2024.100631_bib108","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1038\/s41591-024-03141-0","article-title":"A\u00a0foundation model for clinical-grade computational pathology and rare cancers detection","volume":"30","author":"Vorontsov","year":"2024","journal-title":"Nat Med"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395224002114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395224002114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T02:38:13Z","timestamp":1767235093000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395224002114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":108,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0893395224002114"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2024.100631","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Digital and Computational Pathology Applications in Bladder Cancer: Novel Tools Addressing Clinically Pressing Needs","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2024.100631","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 United States & Canadian Academy of Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100631"}}